WHO's rollout of malaria vaccine in Africa: can safety questions be answered after only 24 months?

BMJ. 2020 Jan 24;368:l6920. doi: 10.1136/bmj.l6920.
No abstract available

MeSH terms

  • Advisory Committees
  • Africa / epidemiology
  • Clinical Trials, Phase III as Topic
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Malaria / mortality
  • Malaria / prevention & control*
  • Malaria Vaccines / adverse effects*
  • Malaria Vaccines / supply & distribution*
  • Malaria, Cerebral / chemically induced*
  • Malaria, Cerebral / mortality
  • Male
  • Meningitis / chemically induced*
  • Meningitis / mortality
  • Patient Safety / statistics & numerical data*
  • Pilot Projects
  • World Health Organization*

Substances

  • Malaria Vaccines